Involvement of σ receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems

European Journal of Pharmacology

Volumn 368, Issue 2-3, 1999, Pages 183-196

  Gronier, Benjamin ^a   Debonnel, Guy ^b  

^a ELI LILLY AND COMPANY   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Caudate nucleus; Dopamine neuron; Extracellular recording; Microiontophoresis; Nucleus accumbens; Substantia nigra compacta; Ventral tegmental area

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PENTAZOCINE; PHENCYCLIDINE; SIGMA OPIATE RECEPTOR; SIGMA RECEPTOR LIGAND;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; ELECTROPHYSIOLOGY; HIPPOCAMPUS; INTRACEREBRAL DRUG ADMINISTRATION; IONTOPHORESIS; MALE; MESENCEPHALON; MODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANALGESICS, OPIOID; ANIMALS; CAUDATE NUCLEUS; CINNAMATES; CYCLOPROPANES; DOPAMINE; ELECTROPHYSIOLOGY; EXCITATORY AMINO ACIDS; GLUTAMIC ACID; GUANIDINES; KAINIC ACID; MALE; N-METHYLASPARTATE; NEURONS; NUCLEUS ACCUMBENS; PENTAZOCINE; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; RECEPTORS, DOPAMINE; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NEUROTRANSMITTER; RECEPTORS, SIGMA; SPIRO COMPOUNDS; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION; THIAZOLES; VENTRAL TEGMENTAL AREA;

EID: 0033018584     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00025-4     Document Type: Article

References (39)

1. Beckstead R.M., Domesick V.B., Nauta W.J. Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res. 175:1979;191-217.
2. Bergeron R., de Montigny C., Debonnel G. Biphasic effects of sigma ligands on the neuronal response to N-methyl-D-aspartate. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:1995;252-260.
3. Bouchard P., Monnet F., Bergeron R., Roman F., Junien J.L., de Montigny C., Debonnel G., Quirion R. In vivo modulation of sigma receptor sites by calcitonin gene-related peptide in the mouse and rat hippocampal formation: radioligand binding and electrophysiological studies. Eur. J. Neurosci. 7:1995;1952-1962.
4. Bunney B.S., Walters J.R., Roth R.H., Aghajanian G.K. Dopaminergic neurons: effects of antipsychotic drugs and amphetamine on single cell activity. J. Pharmacol. Exp. Ther. 185:1973;560-571.
5. Calabresi P., Pisani A., Mercuri N.B., Bernardi G. Heterogeneity of metabotropic glutamate receptors in the striatum: electrophysiological evidence. Eur. J. Neurosci. 5:1993;1370-1377.
6. Chergui K., Charléty P.J., Akaoka H., Saunier C.F., Brunet J.-L., Buda M., Svensson T.H., Chouvet G. Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo. Eur. J. Neurosci. 5:1993;137-144.
7. 2 ligands. Synapse. 29:1998;62-71.
8. Crawley J.N. Cholecystokinin-dopamine interactions. Trends Pharmacol. Sci. 12:1991;232-236.
9. Debonnel G., de Montigny C. Increased neuronal responsiveness to cholecystokinin and dopamine induced by lesioning mesolimbic dopaminergic an electrophysiological study in the rat. Synapse. 2:1988;537-545.
10. Debonnel G., de Montigny C. Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: possible implications for the treatment of psychiatric disorders. Life Sci. 58:1996;721-734.
11. Debonnel G., Monnet F.P., de Montigny C. Further evidence for the modulation of the excitatory effect of NMDA by sigma receptor ligands. FASEB J. 4:1990;A330.
12. 2 ligands. Soc. Neurosci. Abstr. 21:1995;631-637.
13. 3 regions of the dorsal hippocampus: effect of mossy fiber lesioning. Neuroscience. 71:1996;977-987.
14. Earley B., Burke M., Leonard B.E., Gouret C.-J., Junien J.-L. Evidence for an anti-amnesic effect of JO-1784 in the rat: a potent and selective ligand for the sigma receptor. Brain Res. 546:1991;282-286.
15. Grace A.A., Bunney B.S. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons: 1. Identifification and characterization. Neuroscience. 10:1983;301-315.
16. Grace A.A., Bunney B.S. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons: 2. Action potential generating mechanisms and morphological correlates. Neuroscience. 10:1983;317-331.
17. Graybiel A.M., Besson M.J., Weber E. Neuroleptic-sensitivebBinding sites in the nigrostriatal system - evidence for differential distribution of sigma-sites in the subtantia nigra, pars compacta of the cat. J. Neurosci. 9:1989;326-338.
18. 3 dorsal hippocampus. Naunyn-Schmiedeberg's Arch. Pharmacol. 353:1996;382-390.
19. Gudelsky G.A. Effects of σ receptor ligands on the extracellular concentration of dopamine in the striatum and prefrontal cortex of the rat. Eur. J. Pharmacol. 286:1995;223-228.
20. Gué M., Junien J.L., Del Rio C., Bueno L. Neuropeptide Y and sigma ligand (JO-1784) suppress stress-induced colonic motor disturbances in rats through sigma and cholecystokinin receptors. J. Pharmacol. Exp. Ther. 261:1992;850-855.
21. 3H ]-3-(3-Hydroxyphenyl)-N-(1-propyl)piperidine J. Neurosci. 6:1986;1757-1770.
22. Iyengar S., Dilworth V.M., Mick S.J., Contreras P.C., Monahan J.B., Rao T.S., Wood P.L. Sigma receptors modulate both A9 and A10 dopaminergic neurons in the rat brain-functional interaction with NMDA receptors. Brain Res. 524:1990;322-326.
23. Karbon E.W., Abreu M.E., Erickson R.H., Kaiser C., Natalie K.J. Jr., Clissold D.B., Borosky S., Bailey M., Martin L.A.et al. NPC 16377, a potent and selective σ-ligand: I. Receptor binding, neurochemical and neuroendocrine profile. J. Pharmacol. Exp. Ther. 265:1993;866-875.
24. Maurice T., Hiramatsu M., Itoh J., Kameyama T., Hasegawa T. beshi, Nabeshima T. Behavioral evidence for a modulating role of σ ligands in memory processes: I. Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Res. 647:1994;44-56.
25. Maurice T., Hiramatsu M., Itoh J., Kameyama T., Hasegawa T., Nabeshima T. Low dose of 1,3-di(2-tolyl)guanidine (DTG) attenuates MK-801-induced spatial working memory impairment in mice. Psychopharmacology. 114:1994;520-522.
26. Monnet F.P., Debonnel G., Junien J.L., de Montigny C. N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors. Eur. J. Pharmacol. 179:1990;441-445.
27. 3 dorsal hippocampus by sigma ligands. J. Pharmacol. Exp. Ther. 261:1992;123-130.
28. Monnet F.P., Debonnel G., Bergeron R., Gronier B., de Montigny C. The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussis toxin. Br. J. Pharmacol. 112:1994;709-715.
29. Mulder A.B., Manshanden I., Vos P.E., Wolterink G., Van Ree J.M., Lopes D, Silva F.H. Modifications in glutamatergic transmission after dopamine depletion of the nucleus accumbens. A combined in vivo/in vitro electrophysiological study in the rat. Neuroscience. 72:1996;1009-1021.
30. Overton P., Clark D. Iontophoretically administered drugs acting at the N-methyl-D-aspartate receptor modulate burst firing in A9 dopamine neurons in the rat. Synapse. 10:1992;131-140.
31. Patrick S.L., Walker J.M., Perkel J.M., Lockwood M., Patrick R.L. Increases in rat striatal extracellular dopamine and vacuous chewing produced by two σ receptor ligands. Eur. J. Pharmacol. 231:1993;243-249.
32. 2 binding site: 1. 3-(omega-aminoalkyl)-1H-indoles. J. Med. Chem. 38:1995;1998-2008.
33. Phillipson O.T. Afferent projections to the ventral tegmental area of Tsai and interfascicular nucleus: a horseradish peroxidase study in the rat. J. Comp. Neurol. 187:1979;117-143.
34. Poncelet M., Santucci V., Paul R., Gueudet C., Lavastre S., Guitard J., Steinberg R., Terranova J.P., Brelière J.C.et al. Neuropharmacological profile of a novel and selective ligand of the sigma site: SR31742A. Neuropharmacology. 32:1993;605-615.
35. Shepard P.D., Lehmann H., Connelly S.T. Effects of NPC16377, a potent and selective σ receptor ligand, on the activity of mesencephalic dopamine-containing neurons in the rat. Eur. J. Pharmacol. 265:1994;141-149.
36. White F.J., Wang R.Y. Interactions of cholecystokinin and dopamine on nucleus accumbens neurons. Brain Res. 300:1984;161-166.
37. Zhang J., Chiodo L.A., Wettstein J.G., Junien J.L., Freeman A.S. Acute effects of sigma ligands on the electrophysiological activity of rat nigrostriatal and mesoaccumbal dopaminergic neurons. Synapse. 11:1992;267-278.
38. Zhang J., Chiodo L.A., Freeman A.S. Further characterization of the effects of BMY 14802 on dopamine neuronal activity. Synapse. 15:1993;276-284.
39. Zhang J., Chiodo L.A., Wettstein J.G., Junien J.-L., Freeman A.S. Repeated administration of Sigma ligands alters the population activity of rat midbrain dopaminergic neurons. Synapse. 13:1993;223-230.